Epidermal growth factor receptor (EGFR) mutation and personalized therapy in advanced nonsmall cell lung cancer (NSCLC).
- Published in:
- 2013
- By:
- Publication type:
- journal article
Works matching IS 17762596 AND DT 2013 AND VI 8 AND IP 1
Results: 9
1
2
Identification of driver mutations in lung cancer: first step in personalized cancer.
- Published in:
- Targeted Oncology, 2013, v. 8, n. 1, p. 3, doi. 10.1007/s11523-013-0263-z
- By:
- Publication type:
- Article
3
ALK inhibitors: a new targeted therapy in the treatment of advanced NSCLC.
- Published in:
- Targeted Oncology, 2013, v. 8, n. 1, p. 55, doi. 10.1007/s11523-012-0250-9
- By:
- Publication type:
- Article
4
Lung cancer: how to face the revolution?
- Published in:
- 2013
- By:
- Publication type:
- Editorial
5
Clinical meta-analyses of targeted therapies in adenocarcinoma.
- Published in:
- Targeted Oncology, 2013, v. 8, n. 1, p. 35, doi. 10.1007/s11523-013-0262-0
- By:
- Publication type:
- Article
6
Other signalization targets.
- Published in:
- Targeted Oncology, 2013, v. 8, n. 1, p. 69, doi. 10.1007/s11523-012-0246-5
- By:
- Publication type:
- Article
7
Epidermal growth factor receptor ( EGFR) mutation and personalized therapy in advanced nonsmall cell lung cancer (NSCLC).
- Published in:
- Targeted Oncology, 2013, v. 8, n. 1, p. 27, doi. 10.1007/s11523-013-0258-9
- By:
- Publication type:
- Article
8
Update on antiangiogenic treatment of advanced non-small cell lung cancer (NSCLC).
- Published in:
- Targeted Oncology, 2013, v. 8, n. 1, p. 15, doi. 10.1007/s11523-013-0261-1
- By:
- Publication type:
- Article
9
EGFR-directed monoclonal antibodies in non-small cell lung cancer.
- Published in:
- Targeted Oncology, 2013, v. 8, n. 1, p. 47, doi. 10.1007/s11523-012-0244-7
- By:
- Publication type:
- Article